In clinical trials evaluating sumatriptan in the treatment of moderate or severe migraine pain, the 50- and 100-mg doses have been comparably effective and well tolerated. The primary efficacy end ...
Early treatment with sumatriptan tablets (50 and 100 mg) has been shown to be effective in retrospective and prospective study designs. Despite the efficacy of sumatriptan 50 mg and early intervention ...
Sumatriptan is a an Antimigraine Agent belonging to pharmacology class of Serotonin 5-HT1B, 1D Receptor Agonist Class Sumatriptan can be used in the treatment of Cluster headache, acute and Migraine, ...
Sumatriptan (Migratan (100 mg)) is a selective serotonin receptor agonist, prescribed for the acute treatment of migraine attacks with or without aura in adults (severe, throbbing headaches that ...
1. Why am I using CHEMISTS' OWN ACUTE MIGRAINE RELIEF SUMATRIPTAN TABLETS? CHEMISTS' OWN ACUTE MIGRAINE RELIEF SUMATRIPTAN TABLETS contains the active ingredient sumatriptan succinate. CHEMISTS' OWN ...
--Migraine Sufferers Achieved Greater Rates of Pain Relief and Pain Freedom Within 30 Minutes with AVP-825 Treatment Compared with Oral Sumatriptan Treatment-- ALISO VIEJO, Calif., June 10, 2014 ...
Triptans are effective medicines used to treat migraine headaches. They significantly reduce pain within two hours for most people. Complete relief is less common, but the likelihood may be greater if ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories (NYSE:RDY) today announced that it has launched the authorized generic version of GlaxoSmithKline's Imitrex® (sumatriptan succinate) tablets ...
DETROIT, Aug. 11 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. has launched sumatriptan succinate tablets on behalf of Sun Pharmaceutical ...
Ranbaxy announced that it has settled all matters relating to possible patent litigation with GlaxoSmithKline regarding Sumatriptan Succinate tablets, used for treating migraine. NEW DELHI: Ranbaxy ...
Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine --Migraine Sufferers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results